News

HDA UK Media and Political Bulletin – 1 April 2021

Media Summary

EU warns ‘zero’ jabs shipped to UK until AstraZeneca meets bloc’s targets  
Financial Times, George Parker, Sam Fleming and Michael Peel31 March 2021

The Financial Times reports that a senior Brussels policymaker suggested that it is unlikely the UK will obtain AstraZeneca vaccines manufactured in the EU, he said “zero” jabs would be shipped across the Channel if the company failed to meet its commitments to the bloc.

Internal market commissioner, Thierry Breton said that “there is nothing to negotiate” regarding ongoing discussions between London and Brussels over vaccine production.

Breton said production from the Seneffe plant in Belgium and the Halix factory in the Netherlands “more or less” matches AstraZeneca’s commitments to Brussels, and so must be reserved for the EU.

Britain signed an undisclosed initial agreement with AstraZeneca several months before the company made a deal with the EU — although the final UK contract was only sealed the day after the deal with the European bloc.

British officials have discussed “sharing” doses made in Leiden with the EU and the two sides put out a statement last week declaring they wanted to find a “win-win situation and expand vaccine supply for all our citizens”. However, some EU officials are uncertain what the UK can currently offer the EU given the bloc has exported 21m doses of all vaccines to Britain with no production flowing the other way.

Parliamentary Coverage

DHSC counter fraud strategy: 2020 to 2023
Department of Health and Social Care, 30 March 2021

The DHSC counter fraud strategy: 2020 to 2023 sets out the department’s plan to prevent and tackle fraud across the healthcare system.

Fraudulent activity in the NHS takes money away from important patient care and reduces resources available for health services. NHS funding will increase by £33.9 billion by 2023 to 2024, thus a counter-fraud response to protect this investment has become even more important.

Additionally, as the DHSC counter fraud strategy is published, the country continues to respond to the COVID-19 pandemic. During a national emergency, some may take advantage of the situation to commit fraud.

The DHSC strategy will provide direction and a structure focused on accountability, convening and working together. The objective of the strategy is to be a system-wide approach to tackling fraud which protects taxpayer’s money for better patient care.

Full Coverage

EU warns ‘zero’ jabs shipped to UK until AstraZeneca meets bloc’s targets

Financial Times, George Parker, Sam Fleming and Michael Peel31 March 2021

This article is subject to copyright terms and conditions. Please access the full article here.

HDA UK Media and Political Bulletin – 1 April 2021

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?